You have 9 free searches left this month | for more free features.

A2AR

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Coronary Syndromes Trial in Marseille (blood samples)

Recruiting
  • Chronic Coronary Syndromes
  • blood samples
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Dec 20, 2021

Acute Coronary Syndrome Trial in Marseille (blood samples)

Completed
  • Acute Coronary Syndrome
  • blood samples
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Oct 11, 2021

Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • AR-14034 SR implant lower dose
  • +3 more
  • (no location specified)
Mar 3, 2023

Gout, Arthritis, Gouty, Hyperuricemia Trial in Phoenix, Tucson, Myrtle Beach (AR882 Dose 1, AR882 Dose 2, Allopurinol Tablet)

Not yet recruiting
  • Gout
  • +3 more
  • AR882 Dose 1
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jul 13, 2022

Nursing Education Trial in Seoul (AR guidance with Hololens 2)

Completed
  • Nursing Education
  • AR guidance with Hololens 2
  • Seoul, Korea, Republic of
    Samsung Medical Centre
Jun 30, 2022

Type 2 Diabetes Trial in Nanjing (AR group: aerobic training before resistance training, RA group: resistance exercise before

Recruiting
  • Type 2 Diabetes
  • AR group: aerobic training before resistance training
  • RA group: resistance exercise before aerobic exercise
  • Nanjing, Jiangsu, China
    Maigaoqiao Community Health Service Center
Nov 17, 2023

Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 5, 2022

Amputation, Upper Limb Trial in Edmonton (MyoTrain AR, Motor Imagery)

Recruiting
  • Amputation
  • Upper Limb
  • MyoTrain AR
  • Motor Imagery
  • Edmonton, Alberta, Canada
    University of Alberta
Jul 27, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in United States (AR-13503 Implant 10.6 Dose,

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • AR-13503 Implant 10.6 Dose
  • +3 more
  • Gilbert, Arizona
  • +5 more
Jun 9, 2022

Gout, Arthritis, Gouty, Hyperuricemia Trial in Australia, Taiwan, United States (AR882 Dose 1, AR882 Dose 2, Placebo)

Completed
  • Gout
  • +3 more
  • AR882 Dose 1
  • +2 more
  • Gilbert, Arizona
  • +22 more
Jan 30, 2023

Aging Trial in Glendale

Withdrawn
  • Aging
  • (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
  • Control
  • Glendale, Arizona
    Glencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023

Ventilator Associated Pneumonia, Staphylococcus Aureus Trial in Limoges (Suvratoxumab, Placebo)

Recruiting
  • Ventilator Associated Pneumonia
  • Staphylococcus Aureus
  • Suvratoxumab
  • Placebo
  • Limoges, France
    Research Site
Feb 1, 2023

Macular Edema Trial in United States (AR-1105-CF1, AR-1105-CF2)

Completed
  • Macular Edema
  • Phoenix, Arizona
  • +10 more
Feb 15, 2022

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Dry Eye Disease Trial in United States (AR 15512 Ophthalmic Solution, Vehicle)

Recruiting
  • Dry Eye Disease
  • Torrance, California
  • +19 more
Dec 9, 2022

Obesity, Morbid, Bariatric Surgery, Adolescent Trial in Aurora (Phentermine, Immediate Release Topiramate, Placebo for

Completed
  • Obesity, Morbid
  • +4 more
  • Aurora, Colorado
    Children's Hospital Colorado
Mar 7, 2022

Diarrhea Trial in Silver Spring (Invaplex[AR-DETOX], Placebo)

Completed
  • Diarrhea
  • Invaplex[AR-DETOX]
  • Placebo
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research Clinical Trials Center (W
Jul 7, 2021

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

Diabetes Type 2 With Periodontal Disease Trial in Tainan (AR Dental Care Training System)

Recruiting
  • Diabetes Mellitus Type 2 With Periodontal Disease
  • AR Dental Care Training System
  • Tainan, Taiwan
    Chimei Medical Center
Aug 7, 2023

Cystic Fibrosis Trial in United States (Inhaled AR-501, Inhaled Placebo)

Recruiting
  • Cystic Fibrosis
  • Inhaled AR-501
  • Inhaled Placebo
  • Tucson, Arizona
  • +21 more
Apr 12, 2022

SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor

Completed
  • SARS-CoV-2 (COVID-19) Infection
  • Advanced or Metastatic Hematological or Solid Tumor
  • Autophagy inhibitor (GNS651)
  • +3 more
  • Lyon, Rhône, France
  • +11 more
Sep 29, 2022

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Circulating Tumor Cell, Metastatic Prostate Cancer Trial in Netherlands (Cabazitaxel, Antihistamine, Corticosteroid)

Active, not recruiting
  • Circulating Tumor Cell
  • Metastatic Prostate Cancer
  • Delft, Netherlands
  • +8 more
Aug 19, 2021

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial (Pharmacotherapy

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Pharmacotherapy Discontinuation
  • +3 more
  • (no location specified)
Feb 11, 2022

Neurofibromatosis Type 2 Trial in United States (REC-2282, Placebo)

Recruiting
  • Neurofibromatosis Type 2
  • Los Angeles, California
  • +11 more
Aug 5, 2022